NIAGEN BIOSCIENCE, INC. Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31)
NIAGEN BIOSCIENCE, INC. (NAGE) reported Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems · last filed 2017-03-16
- NIAGEN BIOSCIENCE, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2015-01-03 was -$24.29K.
- NIAGEN BIOSCIENCE, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2014-09-27 was $0.00.
- NIAGEN BIOSCIENCE, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2014-06-28 was $0.00.
- NIAGEN BIOSCIENCE, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2014-03-29 was -$21.54K.
- NIAGEN BIOSCIENCE, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2016 was $0.00.
- NIAGEN BIOSCIENCE, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2016 was $0.00.
- NIAGEN BIOSCIENCE, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2015 was -$45.83K.
- NIAGEN BIOSCIENCE, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2013 was -$44.96K.
| Period end | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 3 month as first filed | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 9 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 | ||||
| 2016-01-02 | $0.00 10-K · filed 2017-03-16 | ||||
| 2015-01-03 | -$24.29K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$24.29K derived: sum of 2 quarters · filed 2017-03-16 | -$24.29K derived: sum of 3 quarters · filed 2017-03-16 | -$45.83K 10-K · filed 2017-03-16 | |
| 2014-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | -$21.54K 10-Q · filed 2015-11-12 | -$33.22K derived: sum of 4 quarters · filed 2016-03-17 | |
| 2014-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$21.54K 10-Q · filed 2015-08-13 | -$33.22K derived: sum of 3 quarters · filed 2016-03-17 | -$66.50K derived: sum of 4 quarters · filed 2016-03-17 | |
| 2014-03-29 | -$21.54K 10-Q · filed 2015-05-14 | $21.54K 10-Q · filed 2014-05-08 | -$33.22K derived: sum of 2 quarters · filed 2016-03-17 | -$66.50K derived: sum of 3 quarters · filed 2016-03-17 | |
| 2013-12-28 | -$11.68K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | -$44.96K derived: sum of 2 quarters · filed 2016-03-17 | -$44.96K 10-K · filed 2016-03-17 | ||
| 2013-09-28 | -$33.28K 10-Q · filed 2014-11-06 | -$33.28K 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |